Medical/Pharmaceuticals

Össur hf: CEO Retirement and Succession Plan

STOCKHOLM, Dec. 10, 2021 /PRNewswire/ -- Jon Sigurdsson to retire after 26 years as Össur President and CEO,Sveinn Sölvason appointed President and CEO successor Jon Sigurdsson has decided to retire from his position as President and CEO of Össur. The Board of Directors has appointed Össur CFO,S...

2021-12-10 07:03 1881

Cordis Names George Adams, MD as Chief Medical Officer

MIAMI LAKES, Fla., Dec. 9, 2021 /PRNewswire/ -- Cordis, a global cardiovascular technology company, today announcedGeorge Adams, MD, MHS, MBA, FACC, FSCAI as Chief Medical Officer, furthering the organization's mission to differentiate itself as a technological leader and value-based global medic...

2021-12-09 23:00 2630

AnchorDx Achieves Academic Breakthrough with Deep Methylation Representation Learning Research Paper Accepted by 36th AAAI Conference

GUANGZHOU, China, Dec. 9, 2021 /PRNewswire/ -- AnchorDx, a world-leading developer of cancer screening and early detection solutions, was accepted on December 1, 2021, to present its "Noninvasive Lung Cancer Early Detection via Deep Methylation Representation Learning" research paper (DeepMeth) at...

2021-12-09 22:00 1902

The innovative software "CAAS vFFR" by Pie Medical Imaging for the non-invasive physiological assessment of intermediate coronary lesions is the subject of FAST III, a multicenter European clinical trial which will investigate the effectiveness of the vessel Fractional Flow Reserve (vFFR) guided revascularization as compared to conventional FFR guided revascularization

MAASTRICHT, Netherlands, Dec. 9, 2021 /PRNewswire/ --  Pie Medical Imaging ("PMI"), a global leader in cardiac imaging, part of the Esaote Group, today announced the beginning of FASTIII, a multicenter randomized clinical trial which willinvestigate the use of angiography-based vessel fractional ...

2021-12-09 21:00 2366

Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube

SEOUL, South Korea, Dec. 9, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530),  South Korea's leading molecular diagnostics company, today unveiled another series of diagnostic test that detects the ever-changing COVID-19 variant landscape. The Novaplex™ SARS-CoV-2 Variants VII assay addresses Omicron...

2021-12-09 20:18 1860

Sciwind Biosciences Completes Enrollment in Phase 2 Clinical Trial of XW003 in Type 2 Diabetes Patients

HANGZHOU, China and SAN FRANCISCO, Dec. 9, 2021 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, today announced the completion of patient enrollment in its Phase 2 clin...

2021-12-09 20:00 1988

Another clean interim safety review of RhoVac's clinical phase IIb study in prostate cancer

HELSINKI, Dec. 9, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today onDecember 9th, 2021, that its Data & Safety Monitoring Committee (DSMC) has conducted a planned interim safety review of its clinical phase IIb trial in prostate cancer, known as ...

2021-12-09 16:58 1192

Proximie Partners with Jhpiego in New Initiative to Improve Obstetric Surgical Care

- The Obstetric Safe Surgery (OSS) Project in Kenya is funded by Johnson & Johnson and to date has been implemented by Jhpiego as the lead organization, in collaboration with County and National Ministries of Health and professional associations. - To support implementation moving forward, Proxi...

2021-12-09 15:00 2398

Posters Highlighting clinical data of KN026 presented at SABCS 2021

SUZHOU, China, Dec. 9, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK) jointly announced that two posters highlighting data from two clinicalstudies of the anti-HER2 bispecific antibody KN026 were presented at the 44th San...

2021-12-09 12:20 2092

Lunit Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

SEOUL, South Korea, Dec. 9, 2021 /PRNewswire/ -- CB Insights today named Lunit to its third annual Digital Health 150 , which showcases the 150 most promising private digital healt...

2021-12-09 11:24 1895

Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021

- Trial met both primary endpoints demonstrating statistically significant and clinically meaningful extension of progression free survival (PFS) as monotherapy vs. standard of care (SoC) endocrine therapy in overall population and estrogen receptor mutation (mESR1) population - In the overall p...

2021-12-09 08:38 1980

Servatus raises $7.5 million to advance autoimmune therapies with its microbial biotherapeutics clinical programs

* Servatus has raised $7.5 million in an oversubscribed capital raise, with strong support from sophisticated shareholders * Funds raised will underpin Servatus' live microbial and engineered protein biotherapeutics drug development * Two Phase 1/2 clinical trials to launch shortly in Queens...

2021-12-09 07:35 1926

Brii Bio Announces Amubarvimab/Romlusevimab Combination Received Approval from NMPA as First COVID-19 Neutralizing Antibody Combination Therapy in China

The approval marks the first locally-discovered and approved SARS-CoV-2 target-specific treatment inChina, through a randomized, double-blind and placebo-controlled trial Brii Bio is also seeking U.S. FDA Emergency Use Authorization for the amubarvimab/romlusevimab combination DURHAM, N.C. and ...

2021-12-09 06:10 2814

CRI Online: China's Fangchenggang City Hosts 2021 IMICF

FANGCHENGGANG, China, Dec. 8, 2021 /PRNewswire/ -- A news reported by CRI Online: On December 6, the 2021 International Medical Innovation Cooperation Forum was held in Fangchenggang City,Guangxi Province online and offline.  The scene of...

2021-12-08 21:17 2324

Donisi Health Takes Home First Place in the Prestigious Innovations in Cardiovascular Intervention Competition

MedTech Startup Focused on Home Monitoring for Patients with Congestive Heart Failure and Other Chronic Diseases Wins the 2021 ICI Pitch Competition and $200,000 Award TEL AVIV, Israel, Dec. 8, 2021 /PRNewswire/ -- Donisi Health (Donisi) prevailed in this year's ICI In...

2021-12-08 21:01 1593

Treadwell Therapeutics Announces A Presentation at the 2021 SABCS Annual Meeting Featuring a Clinical Trial Update on CFI-402257, a Best-in-Class TTK inhibitor

NEW YORK and HONG KONG, Dec. 8, 2021 /PRNewswire/ -- Treadwell Therapeutics, today announced a presentation for the Company's CFI-402257 program, an oral, best-in-class TTK inhibitor, at the 2021 San Antonio Breast Cancer Symposium (SABCS) being held from December 7-10, 2021.  This presentation w...

2021-12-08 20:00 2100

China's Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, GenScript ProBio Expanding Manufacturing Capacity Again

NANJING, China, Dec. 8, 2021 /PRNewswire/ -- On December 7th, the "Opening Ceremony of GenScript ProBio Plasmid Commercial GMP Manufacturing facility and Open Day" was rounded off. GenScript ProBio at the opening ceremony announced thatthe largest commercial GMP plasmid manufacturing facility in ...

2021-12-08 18:22 1470

AXA Hong Kong launched exclusive mind health network and online counselling service for Employee Benefits customers

HONG KONG, Dec. 8, 2021 /PRNewswire/ -- As a leading Employee Benefits insurance provider, AXA Hong Kong (AXA) continuously enhances its services to working individuals with a commitment to safeguarding all aspects of their physical and mental wellbeing. To enhance mental health support and to ma...

2021-12-08 18:00 2052

SHL Medical Publishes its Molly Modular Autoinjector Platform Technology White Paper

ZUG, Switzerland, Dec. 8, 2021 /PRNewswire/ -- SHL Medical, a world-leading solutions provider in the design, development, and manufacturing of self-injection devices, announced the publication of its white paper titled, "Molly® Autoinjector: A Systematic Review of Molly's Integrated and Flexible...

2021-12-08 14:00 2333

GSK Provides Update on Manufacturing Operations in Singapore

SINGAPORE, Dec. 8, 2021 /PRNewswire/ -- GSK announced today that it will cease manufacturing and outsource all production of amoxicillin that is currently produced at its Quality Road site inSingapore. Amoxicillin is an active pharmaceutical ingredient (API) in GSK's Augmentin product. This will ...

2021-12-08 09:30 3518
1 ... 186187188189190191192 ... 382